首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

JOURNAL OF THROMBOSIS AND THROMBOLYSIS
ISSN：0929-5305

JOURNAL OF THROMBOSIS AND THROMBOLYSIS

J THROMB THROMBOLYS
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：偏慢,4-8周
新锐分区：医学3区
年发文量：125
影响因子：2.2
JCR分区：Q2

基本信息

《血栓形成与溶栓杂志》是当代心脏病学家、血液病学家、血管医学专家和临床科学家期待已久的资源，他们积极参与涉及心脑血管系统的血栓性疾病的治疗决策和临床研究。该杂志的主要重点是血栓形成和血管疾病的病理生物学，抗凝剂、血小板拮抗剂、细胞治疗和干预在科学研究、临床转化研究和患者护理中的应用。该杂志将发表原创作品，强调基本科学原理和临床研究之间的接口。促进血栓形成和血管科学的跨学科和学术对话。已发表的作品还将定义转化研究、药物开发、临床试验和以患者为导向的应用的平台。《血栓形成与溶栓杂志》的综合形式将扩大读者的知识库，并为研究和直接临床应用提供重要的见解，这些研究和直接临床应用是医学中最迅速发展的领域-血栓形成和血管科学。
0929-5305SCIE/Scopus收录
2.2
点击查看最新影响趋势>
2
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
HEMATOLOGY 血液学
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q2
111/231
学科：HEMATOLOGY
SCIE
Q3
51/99
学科：PERIPHERAL VASCULAR DISEASE
SCIE
Q3
50/98
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q2
111/231
学科：HEMATOLOGY
SCIE
Q2
43/100
学科：PERIPHERAL VASCULAR DISEASE
SCIE
Q3
50/99
59
125
点击查看年发文量趋势图>
9%容易偏慢,4-8周-医学-外周血管病
4.5%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
84.00%25.81%-
CiteScore：6.60
SJR：0.736
SNIP：0.732
学科类别分区排名百分位
大类：Medicine
小类：Cardiology and Cardiovascular Medicine
Q1
75 / 397
大类：Medicine
小类：Hematology
Q1
28 / 142

期刊高被引文献

Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01923-9
Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01931-9
Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01876-z
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01962-2
“Blueprinting” thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01813-0
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01823-y
A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01851-8
Characterisation of acute ischemic stroke in patients with left ventricular thrombi after myocardial infarction
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01829-6
ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01941-7
What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01891-0
Development of an algorithm for the systematic evaluation of patients with suspected heparin-induced thrombocytopenia
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01828-7
The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01949-z
Venous thromboembolism in patients with cancer undergoing surgical exploration
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-018-1774-3
Does the administration of sonothrombolysis along with tissue plasminogen activator improve outcomes in acute ischemic stroke? A systematic review and meta-analysis
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01899-6
Ibrutinib related bleeding complications in elderly patients with B cell malignancies
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01907-9
D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01964-0
Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01932-8
The value of sPESI for risk stratification in patients with pulmonary embolism
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01814-z
Use of oral anticoagulant drugs is associated with carotid intraplaque hemorrhage in atherosclerosis patients: a meta-analysis
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01865-2
Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01959-x
Off-pump technique and replacement therapy for coronary artery bypass surgery in a patient with hemophilia B
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01888-9
Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosis
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01903-z
Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01832-x
Severe pulmonary tuberculosis complicated with insidious pulmonary thromboembolism: a case report and literature review
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01967-x
Effect of emicizumab on global coagulation assays for plasma supplemented with apixaban or argatroban
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01993-9
Incidence and risk of venous thromboembolism in patients following appendectomy: a nationwide cohort study
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01890-1
Genetic factors affecting thrombosis in patients with essential thrombocythemia by heparin treatment
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01886-x
Performance of the right ventricular outflow tract/aortic diameter as a novel predictor of risk in patients with acute pulmonary embolism
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-02021-6
Prolonged activated partial thromboplastin time after prophylactic-dose unfractionated heparin in the post-operative neurosurgical setting: case series and management recommendations
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01936-4
Appropriateness of thrombophilia testing in patients in the acute care setting and an evaluation of the associated costs
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01930-w
The efficacy and safety of a catheter removal only strategy for the treatment of PICC line thrombosis versus standard of care anticoagulation: a retrospective review
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01807-y
Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-02015-4
Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01848-3
Reduced dose thrombolysis with ultrasound-facilitated catheter-directed administration for acute pulmonary embolism reduces length of stay
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-02009-2
Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01914-w
Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01999-3
Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-02017-2
Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01898-7
Universal venous thromboembolism policy is effective but may not adequately protect hospitalized cancer patients with larger BMI
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01975-x
Increased exercise-related platelet activation assessed by impedance aggregometry in diabetic patients despite aspirin therapy
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01825-w
“Minor” stroke: not a minor, still open question
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-02001-w
Highlights from the 2018 European Society of Cardiology Congress in Munich, Germany
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01810-3
Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01809-w
Life after abciximab; what’s next for intracoronary thrombus?
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01977-9
The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01928-4
Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01944-4
Paradoxical migration of an arterial embolus upstream from the fistula during a percutaneous thrombectomy procedure
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01895-w
Blood type association with bleeding outcomes at delivery in a large multi-center study
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-02023-4
Different manifestations of patients with inhibitors against prothrombin and thrombin
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01948-0
Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al.
来源期刊：Journal of Thrombosis and ThrombolysisDOI：10.1007/s11239-019-01960-4

相关文章

JOURNAL OF THROMBOSIS AND THROMBOLYSIS，速度很快、国人贡献第二的期刊
2025-07-03
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
HEMATOLOGY 血液学
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
HEMATOLOGY 血液学
3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
PERIPHERAL VASCULAR DISEASE 外周血管病
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
HEMATOLOGY 血液学
3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
PERIPHERAL VASCULAR DISEASE 外周血管病
4区
否
否